Financial Times FT.com

Roche 'unlikely to win' lawsuit to invalidate Ventana's poison pill, could proceed with proxy contest, legal experts say

By Beth Herskovits in New York

Published: November 7 2007 17:13 | Last updated: November 7 2007 17:13

Email options

The information entered on this page will not be used to send unsolicited email, and will not be sold to a 3rd party.Terms of use |Privacy policy

* required fields



(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)